Federation des caisses Desjardins du Quebec’s Genetic Technologies Ltd. GENE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-400
| Closed | -$310 | – | 2672 |
|
|
2024
Q3 | $310 | Hold |
400
| – | – | ﹤0.01% | 2430 |
|
|
2024
Q2 | $600 | Hold |
400
| – | – | ﹤0.01% | 2240 |
|
|
2024
Q1 | $1.16K | Hold |
400
| – | – | ﹤0.01% | 2179 |
|
|
2023
Q4 | $960 | Hold |
400
| – | – | ﹤0.01% | 2154 |
|
|
2023
Q3 | $1.53K | Hold |
400
| – | – | ﹤0.01% | 2107 |
|
|
2023
Q2 | $1.66K | Hold |
400
| – | – | ﹤0.01% | 2083 |
|
|
2023
Q1 | $2.32K | Hold |
400
| – | – | ﹤0.01% | 2062 |
|
|
2022
Q4 | $1.86K | Hold |
400
| – | – | ﹤0.01% | 2212 |
|
|
2022
Q3 | $2.34K | Hold |
400
| – | – | ﹤0.01% | 2237 |
|
|
2022
Q2 | $2.32K | Hold |
400
| – | – | ﹤0.01% | 2289 |
|
|
2022
Q1 | $3.94K | Hold |
400
| – | – | ﹤0.01% | 2249 |
|
|
2021
Q4 | $3.76K | Hold |
400
| – | – | ﹤0.01% | 2264 |
|
|
2021
Q3 | $6.18K | Hold |
400
| – | – | ﹤0.01% | 2182 |
|
|
2021
Q2 | $8.5K | Hold |
400
| – | – | ﹤0.01% | 2093 |
|
|
2021
Q1 | $8.34K | Buy |
400
+200
| +100% | +$4.58K | ﹤0.01% | 2051 |
|
|
2020
Q4 | $3.6K | Hold |
200
| – | – | ﹤0.01% | 2140 |
|
|
2020
Q3 | $3.46K | Buy |
+200
| New | +$3.73K | ﹤0.01% | 1938 |
|
|
2019
Q1 | – | Sell |
-23
| Closed | -$246 | – | 2139 |
|
|
2018
Q4 | $246 | Hold |
23
| – | – | ﹤0.01% | 2024 |
|
|
2018
Q3 | $491 | Buy |
+23
| New | +$522 | ﹤0.01% | 2079 |
|
Other funds holding GENE
Federation des caisses Desjardins du Quebec's GENE Position: Q4 2024 in Review
Federation des caisses Desjardins du Quebec sold out of Genetic Technologies Ltd. (GENE) in Q4 2024, closing a stake of 400 shares — an estimated $310 sold.
Federation des caisses Desjardins du Quebec first reported a position in GENE in Q3 2018 and held it in 19 quarters. The position peaked at $8.5K in Q2 2021. 1 fund tracked by Wall St. Rank holds GENE as of Q4 2024.
- Federation des caisses Desjardins du Quebec reported no remaining Genetic Technologies Ltd. position as of Q4 2024 after selling out during the quarter.
- Federation des caisses Desjardins du Quebec sold 400 Genetic Technologies Ltd. shares in Q4 2024, an estimated $310.
- Federation des caisses Desjardins du Quebec first reported a position in Genetic Technologies Ltd. in Q3 2018 and held it in 19 quarters.
- Federation des caisses Desjardins du Quebec's Genetic Technologies Ltd. position peaked at $8.5K in Q2 2021.
- 1 fund tracked by Wall St. Rank held Genetic Technologies Ltd. as of Q4 2024.
Based on Federation des caisses Desjardins du Quebec's 13F filing for Q4 2024, filed 14 Feb 2025.